Healios K.K.'s Unattributed Round

Healios K.K. raised a round of funding on October 08, 2013.

Healios K.K. aims to commercialize the world's first pharmaceutical hiPSC derived RPE cell transplantation for treatment of AMD in collaboration with RIKEN, one of the leading research institutes in J…

Articles about Healios K.K.'s Unattributed Round: